Investing
Top Pre-Market Analyst Upgrades (ABMD, ASML, CBG, EMR, LLTC, MATK, NFLX, PEP)
Published:
These are some of the top pre-market analyst upgrades and positive calls which we have seen early this Wednesday morning:
Abiomed (ABMD) Raised to Buy at UBS.
ASML (ASML) Raised to Buy at ING.
CB Richard Ellis (CBG) Raised to Overweight at JPMorgan; Raised to Outperform at JMP.
Emerson Electric (EMR) Cut to Neutral at Goldman Sachs.
Linear TEch (LLTC) Raised to Overweight at Thomas Weisel.
Martek Biosciences (MATK) Started as Buy at Cantor.
Netflix (NFLX) Started as Market Perform at William Blair.
Pepsico (PEP) Raised to Buy at UBS.
JON C. OGG
In 20 Years, I Haven’t Seen A Cash Back Card This Good
After two decades of reviewing financial products I haven’t seen anything like this. Credit card companies are at war, handing out free rewards and benefits to win the best customers.
A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges.
Our top pick today pays up to 5% cash back, a $200 bonus on top, and $0 annual fee. Click here to apply before they stop offering rewards this generous.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.